Noninvasive Transcutaneous Glucometer Development

NCT01168076 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2010-07-22

No results posted yet for this study

Summary

The objective of this study is to assist in the development of a noninvasive device for the accurate measurement of blood glucose levels.

Conditions

  • Healthy
  • Prediabetic State (IGT)
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1

Sponsors & Collaborators

  • InLight Solutions

    lead INDUSTRY

Principal Investigators

  • Mark Rohrscheib, M.D. · UNMHSC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-12-31
Primary Completion
2008-01-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01168076 on ClinicalTrials.gov